Novo Nordisk A/S | Lånekapital



Loan Capital Ändra Datum
Bausch Health Companies USD 21.05B 154M 2024-09
Bristol-Myers Squibb USD 47.6B 1.07B 2024-12
Eli Lilly USD 28.53B 518.3M 2024-12
GlaxoSmithKline GBP 14.64B 1.39B 2024-12
Merck USD 34.46B 520M 2024-12
Novartis USD 22.93B 2.41B 2024-12
Novo Nordisk 51.45B 156M 2024-09
Novo Nordisk DKK 51.45B 156M 2024-09
Pacira USD 383.54M 2.35M 2024-12
Sanofi 12.5B 1.84B 2024-06
Supernus Pharmaceuticals USD 0 0 2024-12



Novo Nordisk A/S Lånekapital - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.